Clinical Trial Update: HE4 is a Beneficial Biomarker in Endometrial Cancer

View source ↗

Summary

A clinical trial update notes research on HE4 as a biomarker in endometrial cancer conducted by Ain Shams University; no outcome or trial status is provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Ain Shams University | Conditions: Endometrial Cancer | Status: UNKNOWN